Skip to content

Development and validation of a psychological measure and derived short screener to estimate the risk to develop personality disorders based upon the taxation of ultra-high risk domains

Development and validation of a psychological measure and derived short screener to estimate the risk to develop personality disorders based upon the taxation of ultra-high risk domains - Preventive Detection Personality Disorders (PDPD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57150
Enrollment
325
Registered
2024-09-30
Start date
2025-02-24
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality Disorders Personality problems

Interventions

Sponsors

De Viersprong
Lead Sponsor

Eligibility

Age
2 Years to 15 Years

Inclusion criteria

Inclusion criteria: For this study, children (and their parent) between 11 and 15 years will be  recruited from risk samples and cohort samples.The risk samples will be  recruited in the Netherlands (within the Viersprong and a number of foster care  services) on the one hand, and within Flemish General Paediatrics (AP) and  Child and Adolescent Psychiatry services on the other. Within de Viersprong, we  recruit in two treatment programmes: MST-CAN (children with documented  intrafamilial experiences of abuse or severe neglect) and MBT-early (children  with incipient features of Borderline PD). From existing research  collaborations between Ghent University and a number of Flemish AP and KJP  services, additional young teenagers with incipient characteristics of  Borderline PD will be recruited. A third risk sample will be recruited in  collaboration with the foster care services Vigere and Sterkhuis. The first and  third high-risk samples are recruited because, by definition, there are  interpersonal traumatic experiences in childhood, which is seen as a major risk  factor for the development of personality problems. The second risk sample is  recruited because, by definition, there are (incipient) characteristics of BPD,  which is a demonstrated risk factor for the development of PD in late  adolescence and young adulthood as well as for social, community and health  problems. The cohort sample is a 'convenience' sample that we will include  mainly to recruit children with a presumed low-risk on the various risk  factors. These participants will be recruited through schools. Through quota  sampling, predetermined quotas for age and socio-economic status will be set to  ensure representativeness of the sample. Participants in each sample will  always be the children/young people and one of the (foster) parents or other  caregiver who assumes a close parenting role.

Exclusion criteria

Exclusion criteria: Inability to participate in interviews or questionnaires due to insufficient command of language, intelligence or for other reasons

Design outcomes

Primary

MeasureTime frame
At baseline, the various instruments belonging to the four appraisals are administered: interpersonal trauma (JTV), personality functioning (STiP-5.1 KV + PV, LoPF-Q), social support system (QSS-A) and onset characteristics of PD, both symptom-based (SCID-5-P, BPFSC) and trait-based (DIPSI-BPS traits). We also conduct baseline measurement of psychosocial functioning (KidScreen, SMA, Social Support, school functioning and Promis Peer). Here we choose a multi-method and multi-informant approach, as reflected in a set of instruments with both self-reporting and reporting by others. In follow-up, the same instruments will be administered, with the exception of the trauma questionnaire. However, a modified survey of recent life events will be added. A detailed description of all instruments is attached. The primary predictable outcome is the presence or absence of a personality disorder after 36 months.

Secondary

MeasureTime frame
See above

Countries

Netherlands

Contacts

Public ContactW. Hauspie

De Viersprong

wiesje.hauspie@deviersprong.nl+31626022685

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026